890 related articles for article (PubMed ID: 24003852)
1. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI of cervical cancers: temporal percentile screening of contrast enhancement identifies parameters for prediction of chemoradioresistance.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e485-92. PubMed ID: 22014954
[TBL] [Abstract][Full Text] [Related]
3. DCE-MRI of locally-advanced carcinoma of the uterine cervix: Tofts analysis versus non-model-based analyses.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Radiat Oncol; 2020 Apr; 15(1):79. PubMed ID: 32293487
[TBL] [Abstract][Full Text] [Related]
4. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.
Yang C; Stadler WM; Karczmar GS; Milosevic M; Yeung I; Haider MA
Magn Reson Med; 2010 Jun; 63(6):1601-9. PubMed ID: 20512864
[TBL] [Abstract][Full Text] [Related]
5. Cluster analysis of dynamic contrast enhanced MRI reveals tumor subregions related to locoregional relapse for cervical cancer patients.
Torheim T; Groendahl AR; Andersen EK; Lyng H; Malinen E; Kvaal K; Futsaether CM
Acta Oncol; 2016 Nov; 55(11):1294-1298. PubMed ID: 27564398
[TBL] [Abstract][Full Text] [Related]
6. Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.
Zahra MA; Tan LT; Priest AN; Graves MJ; Arends M; Crawford RA; Brenton JD; Lomas DJ; Sala E
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):766-73. PubMed ID: 19019563
[TBL] [Abstract][Full Text] [Related]
7. Unified platform for multimodal voxel-based analysis to evaluate tumour perfusion and diffusion characteristics before and after radiation treatment evaluated in metastatic brain cancer.
Coolens C; Driscoll B; Foltz W; Svistoun I; Sinno N; Chung C
Br J Radiol; 2019 Apr; 92(1096):20170461. PubMed ID: 30235004
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic analysis of DCE-MRI data of locally advanced cervical carcinoma with the Brix model.
Lund KV; Simonsen TG; Kristensen GB; Rofstad EK
Acta Oncol; 2019 Jun; 58(6):828-837. PubMed ID: 30810443
[No Abstract] [Full Text] [Related]
9. Pharmacokinetic parameters derived from dynamic contrast enhanced MRI of cervical cancers predict chemoradiotherapy outcome.
Andersen EK; Hole KH; Lund KV; Sundfør K; Kristensen GB; Lyng H; Malinen E
Radiother Oncol; 2013 Apr; 107(1):117-22. PubMed ID: 23333024
[TBL] [Abstract][Full Text] [Related]
10. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
[TBL] [Abstract][Full Text] [Related]
12. Comparison of DCE-MRI kinetic parameters and FMISO-PET uptake parameters in head and neck cancer patients.
Simoncic U; Leibfarth S; Welz S; Schwenzer N; Schmidt H; Reischl G; Pfannenberg C; Fougère C; Nikolaou K; Zips D; Thorwarth D
Med Phys; 2017 Jun; 44(6):2358-2368. PubMed ID: 28317128
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
14. Perfusion parameters of intravoxel incoherent motion based on tumor edge region of interest in cervical cancer: evaluation of differentiation and correlation with dynamic contrast-enhanced MRI.
Wang H; Zhu L; Li G; Zuo M; Ma X; Wang J
Acta Radiol; 2020 Aug; 61(8):1087-1095. PubMed ID: 31825761
[TBL] [Abstract][Full Text] [Related]
15. A comparison of dynamic contrast-enhanced CT and MR imaging-derived measurements in patients with cervical cancer.
Kim SM; Haider MA; Milosevic M; Yeung IW
Clin Physiol Funct Imaging; 2013 Mar; 33(2):150-61. PubMed ID: 23383694
[TBL] [Abstract][Full Text] [Related]
16. Perfusion-sensitive parameters of intravoxel incoherent motion MRI in rectal cancer: evaluation of reproducibility and correlation with dynamic contrast-enhanced MRI.
Yang X; Xiao X; Lu B; Chen Y; Wen Z; Yu S
Acta Radiol; 2019 May; 60(5):569-577. PubMed ID: 30114928
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Relationship Between Dynamic Contrast-Enhanced MRI (DCE-MRI) Parameters and Pathological Characteristics in Breast Cancer.
Kang SR; Kim HW; Kim HS
J Magn Reson Imaging; 2020 Nov; 52(5):1360-1373. PubMed ID: 32524658
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
Banks TI; von Eyben R; Hristov D; Kidd EA
Cancer Med; 2018 Aug; 7(8):3642-3651. PubMed ID: 29963760
[TBL] [Abstract][Full Text] [Related]
19. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.
Kierkels RG; Backes WH; Janssen MH; Buijsen J; Beets-Tan RG; Lambin P; Lammering G; Oellers MC; Aerts HJ
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):400-8. PubMed ID: 19733445
[TBL] [Abstract][Full Text] [Related]
20. Repeatability and correlations of dynamic contrast enhanced and T2* MRI in patients with advanced pancreatic ductal adenocarcinoma.
Klaassen R; Gurney-Champion OJ; Wilmink JW; Besselink MG; Engelbrecht MRW; Stoker J; Nederveen AJ; van Laarhoven HWM
Magn Reson Imaging; 2018 Jul; 50():1-9. PubMed ID: 29476781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
